Normalizing function of tumor vessels: progress, opportunities, and challenges

JD Martin, G Seano, RK Jain - Annual review of physiology, 2019 - annualreviews.org
Abnormal blood and lymphatic vessels create a hostile tumor microenvironment
characterized by hypoxia, low pH, and elevated interstitial fluid pressure. These …

Fibroblasts fuel immune escape in the tumor microenvironment

EA De Jaeghere, HG Denys, O De Wever - Trends in cancer, 2019 - cell.com
Immune escape is central to the persistence of most, if not all, solid tumors and poses a
critical obstacle to successful cancer (immuno) therapy. Cancer-associated fibroblasts …

Quantification of microenvironmental metabolites in murine cancers reveals determinants of tumor nutrient availability

MR Sullivan, LV Danai, CA Lewis, SH Chan, DY Gui… - Elife, 2019 - elifesciences.org
Cancer cell metabolism is heavily influenced by microenvironmental factors, including
nutrient availability. Therefore, knowledge of microenvironmental nutrient levels is essential …

Total neoadjuvant therapy with FOLFIRINOX in combination with losartan followed by chemoradiotherapy for locally advanced pancreatic cancer: a phase 2 clinical …

JE Murphy, JY Wo, DP Ryan, JW Clark, W Jiang… - JAMA …, 2019 - jamanetwork.com
Importance Patients with locally advanced pancreatic cancer have historically poor
outcomes. Evaluation of a total neoadjuvant approach is warranted. Objective To evaluate …

Blocking CXCR4 alleviates desmoplasia, increases T-lymphocyte infiltration, and improves immunotherapy in metastatic breast cancer

IX Chen, VP Chauhan, J Posada… - Proceedings of the …, 2019 - National Acad Sciences
Metastatic breast cancers (mBCs) are largely resistant to immune checkpoint blockade, but
the mechanisms remain unclear. Primary breast cancers are characterized by a dense …

Losartan treatment enhances chemotherapy efficacy and reduces ascites in ovarian cancer models by normalizing the tumor stroma

Y Zhao, J Cao, A Melamed, M Worley… - Proceedings of the …, 2019 - National Acad Sciences
In ovarian cancer patients, tumor fibrosis and angiotensin-driven fibrogenic signaling have
been shown to inversely correlate with survival. We sought to enhance drug delivery and …

Reprogramming the microenvironment with tumor-selective angiotensin blockers enhances cancer immunotherapy

VP Chauhan, IX Chen, R Tong… - Proceedings of the …, 2019 - National Acad Sciences
Cancer-associated fibroblasts (CAFs) can either suppress or support T lymphocyte activity,
suggesting that CAFs may be reprogrammable to an immunosupportive state. Angiotensin …

[HTML][HTML] Reprogramming the tumor microenvironment to improve immunotherapy: emerging strategies and combination therapies

M Datta, LM Coussens, H Nishikawa… - American Society of …, 2019 - ncbi.nlm.nih.gov
Emerging immunotherapeutic approaches have revolutionized the treatment of multiple
malignancies. Ime-mune checkpoint blockers (ICBs) have enabled never-before-seen …

Vascular regulation of antitumor immunity

LL Munn, RK Jain - Science, 2019 - science.org
Immunotherapy with immune checkpoint blockers (ICBs) has revolutionized cancer
treatment. Unfortunately, ICB therapy usually benefits< 15% of patients and causes immune …

Programmed cell death protein‐1 (PD‐1)‐targeted immunotherapy in advanced hepatocellular carcinoma: efficacy and safety data from an international multicentre …

B Scheiner, MM Kirstein, F Hucke… - Alimentary …, 2019 - Wiley Online Library
Background Programmed cell death protein‐1‐targeted immunotherapy has shown
promising results in phase II studies of hepatocellular carcinoma. Aim To evaluate safety …